Integrating Pathophysiology in Migraine: Role of the Gut Microbiome and Melatonin.
Clicks: 521
ID: 48882
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
77.4
/100
521 views
346 readers
Trending
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #2 of 120 articles by views in current pharmaceutical design
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
The pathoetiology and pathophysiology of migraine are widely accepted as unknown. The current article overviews the wide array of data associated with the biological underpinnings of migraine and provides a framwork that integrates previously disparate bodies of data. The importance of alterations in stress- and pro-inflammatory cytokine- induced gut dysbiosis, especially butyrate production, is highlighted. This is linked to a decrease in the availability of melatonin, and a relative increase in the N-acetylserotonin/melatonin ratio, which has consequences for the increased glutamatergic excitatory transmission in migraine. It is proposed that suboptimal mitochondria functioning and metabolic regulation drive alterations in astrocytes and satellite glial cells that underpin the vasoregulatory and nociceptive changes in migraine. This provides a framework not only for classical migraine associated factors, such as calcitonin-gene related peptide and serotonin, but also for a developmental pathoetiology of migraine. A number of future research and treatment implications arise, including the clinical utilization of sodium butyrate and melatonin in the management of migraine.
| Reference Key |
anderson2019integratingcurrent
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Anderson, George; |
| Journal | current pharmaceutical design |
| Year | 2019 |
| DOI |
10.2174/1381612825666190920114611
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.